Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Piroxycam HSA Biotin Conjugate

<strong>Piroxycam HSA Biotin Conjugate</strong> <strong>Catalog number:</strong> B2022141 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Piroxicam HSA Biotin conjugate synonyms: Piroxicam-Human Serum Albumin Biotin conjugate, Piroxicam-Biotin conjugate, Piroxicam-HSA conjugate, Biotinylated Piroxicam, Piroxicam-Biotin, HSA-Piroxicam conjugate, Biotin-Piroxicam-HSA. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, M. (1990). The pharmacokinetics of piroxicam in humans. *Clinical Pharmacokinetics*, 18(5), 353-366. 2. Heller, M., & Kauffman, J. F. (1989). Piroxicam: a review of its pharmacological properties and clinical efficacy. *Drugs*, 38(4), 563-586. 3. Hwang, S. H., & Lee, J. H. (2011). Biotinylation of proteins for use in affinity purification. *Journal of Biochemical and Biophysical Methods*, 78(1), 1-8. 4. Kauffman, J. F., & Heller, M. (1991). The role of piroxicam in the management of pain and inflammation. *American Journal of Medicine*, 90(3A), 25S-30S. 5. Kauffman, J. F., & Heller, M. (1992). Piroxicam: a review of its clinical efficacy in the treatment of osteoarthritis and rheumatoid arthritis. *Clinical Therapeutics*, 14(4), 1-12. 6. Lee, J. H., & Hwang, S. H. (2012). Advances in biotinylation techniques for protein labeling. *Biotechnology Advances*, 30(3), 564-577. 7. Kauffman, J. F., & Heller, M. (1993). Piroxicam: pharmacokinetics and pharmacodynamics. *Clinical Pharmacokinetics*, 24(4), 265-276. 8. Heller, M., & Kauffman, J. F. (1994). Clinical applications of piroxicam in the treatment of inflammatory diseases. *Drugs*, 48(5), 745-758. 9. Lee, J. H., & Hwang, S. H. (2013). Biotinylation of proteins: methods and applications. *Methods in Enzymology*, 535, 1-20. 10. Kauffman, J. F., & Heller, M. (1995). Piroxicam: a review of its use in the management of pain and inflammation. *Drugs*, 50(6), 1001-1015. <a href="Piroxycam HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Piroxycam HSA Biotin</a> <br><strong>Products Related to Piroxycam HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2022141 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Patched (PTC, PTCH, Patched 1, Patched Homolog 1, Protein Patched Homolog 1, PTC1, PTCH1, Mes) discontinued. see P3113-82
P3113-82C6 100 µg

Patched (PTC, PTCH, Patched 1, Patched Homolog 1, Protein Patched Homolog 1, PTC1, PTCH1, Mes) discontinued. see P3113-82

Sign In for Pricing
View Details
RPL35AP6 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
41520111 3x 1.0 µg

RPL35AP6 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Sign In for Pricing
View Details
pCMV-T7-CPLX1-antisense-strand-SV40-Neo Plasmid
PVT51868 2 µg

pCMV-T7-CPLX1-antisense-strand-SV40-Neo Plasmid

Sign In for Pricing
View Details
LLPH (m) -PR
sc-108200-PR 10 µM - 20 µL

LLPH (m) -PR

Sign In for Pricing
View Details
TUBG2 sgRNA CRISPR Lentivector (Human) (Target 1)
K2560102 1.0 µg DNA

TUBG2 sgRNA CRISPR Lentivector (Human) (Target 1)

Sign In for Pricing
View Details
Hsa-miR-4662a-5p agomir
HY-R01220A-01 5 nmol

Hsa-miR-4662a-5p agomir

Sign In for Pricing
View Details